← All Beigene, LTD filings

Beigene, LTD Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

BGNE
Beigene, LTD
SCHEDULE: Baker Bros. Advisors Increases BeOne Medicines Stake
Baker Bros. Advisors LP and affiliated entities have amended their Schedule 13D filing, reporting a combined beneficial ownership of approximately 8.0% of BeOne Medicines Ltd. ordinary shares following a board appointment.
BGNE
Beigene, LTD
SCHEDULE: Baker Bros. Advisors Updates BeOne Medicines Stake
Baker Bros. Advisors filed an amendment to their Schedule 13D regarding their 8.0% beneficial ownership in BeOne Medicines Ltd.
BGNE
Beigene, LTD
SCHEDULE 13D/A: Hillhouse Funds Significantly Reduce BeiGene Stake, File Final Exit Amendment
HHLR Advisors and Hillhouse Investment Management have filed their final Schedule 13D amendment, disclosing a significant reduction in their beneficial ownership of BeiGene, Ltd. ordinary shares to 4.9% following a recent block trade.
BGNE
Beigene, LTD
SCHEDULE 13D/A: Hillhouse Affiliates Reduce BeiGene Stake Through Significant ADS Sale
HHLR Advisors and Hillhouse Investment Management, affiliates under common control, have reduced their beneficial ownership in BeiGene, Ltd. to 6.7% following the sale of 2.48 million American Depositary Shares.